Bioequivalence Study for Fluticasone Propionate 100 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Clinical trial NCT05697003 · UNKNOWN
Trial details
- NCT number
- NCT05697003
- Sponsor
- Respirent Pharmaceuticals Co Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-17
- Primary completion
- 2023-03-31
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.